Corbus Pharmaceuticals Holdings Balance Sheet (2013-2025) | CRBP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	3.38M	32.22M	37.12M	18.26M	12.94M	21.78M	12.44M	3.81M	7.32M	6.62M	2.00M	9.70M	4.96M	19.18M	19.42M	12.15M	18.90M	17.75M	25.48M	27.14M
Short-term Investments (Quarter)	0.35M	70.37M	0.19M	72.64M	0.19M	47.53M	53.79M	0.19M	36.90M	28.22M	17.48M	0.19M	0.28M	123.34M	0.28M	131.86M	0.28M	96.55M	0.28M	0.67M
Cash & Current Investments (Quarter)	3.73M	102.59M	37.31M	90.90M	13.13M	69.32M	66.23M	4.00M	44.23M	34.84M	19.48M	9.89M	5.24M	142.52M	19.71M	144.01M	19.18M	114.30M	25.77M	27.81M
Receivables - Net (Quarter)	2.50M	2.50M	2.50M
Receivables - Other (Quarter)	2.27M	2.40M	2.50M
Receivables (Quarter)	4.77M	4.90M	5.00M
Prepaid Assets (Quarter)	3.66M	2.63M	2.11M	2.37M	2.16M	1.74M	0.93M	0.79M	1.45M	1.52M	2.28M	2.45M	1.31M	1.00M	1.24M	3.63M	4.29M	5.95M	3.30M	3.02M
Current Assets (Quarter)	130.29M	111.58M	111.67M	100.20M	88.48M	75.24M	67.35M	60.18M	45.86M	38.27M	31.21M	23.55M	121.70M	148.31M	160.89M	152.98M	137.36M	122.83M	107.57M	166.95M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	3.79M	3.52M	2.65M	2.39M	2.21M	1.99M	1.80M	1.61M	1.43M	1.27M	1.12M	0.97M	0.82M	0.67M	0.52M	0.39M	0.30M	0.25M	0.20M	0.16M
Long-Term Investments (Quarter)								16.75M
Other Non-Current Assets (Quarter)	0.67M	0.00M	0.48M	0.05M	0.08M	0.48M	0.48M	0.16M	0.18M	0.48M	0.48M	0.21M		0.67M		0.39M	0.39M	0.39M	0.39M	1.80M
Non-Current Assets (Quarter)	9.86M	9.03M	7.91M	7.53M	7.20M	6.83M	6.48M	6.13M	5.78M	5.45M	5.08M	4.73M	4.05M	3.67M	3.28M	2.90M	2.57M	2.26M	1.94M	1.24M
Assets (Quarter)	140.15M	120.61M	119.57M	107.73M	95.68M	82.07M	73.83M	66.31M	51.65M	43.72M	36.28M	28.27M	125.74M	151.98M	164.17M	155.88M	139.93M	125.08M	109.51M	168.19M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.62M	1.88M	2.55M	1.78M	2.70M	1.99M	1.37M	2.17M	1.32M	1.51M	4.71M	3.18M	2.08M	1.15M	2.89M	4.79M	4.07M	3.99M	2.74M	2.21M
Notes Payables (Quarter)	0.41M	0.10M		0.77M	0.44M	0.11M		0.35M	0.20M	0.05M		0.30M	0.19M	0.08M
Payables (Quarter)	4.02M	1.98M	2.55M	2.55M	3.14M	2.10M	1.37M	2.53M	1.53M	1.56M	4.71M	3.48M	2.27M	1.23M	2.89M	4.79M	4.07M	3.99M	2.74M	2.21M
Accumulated Expenses (Quarter)	3.75M	15.09M	3.34M	10.09M	5.50M	4.72M	1.71M	2.22M			1.67M	11.03M	1.45M	2.30M	1.82M	2.28M	5.90M	1.85M	12.58M	2.86M
Other Accumulated Expenses (Quarter)	1.28M	1.51M	1.36M	1.74M
Short term Debt (Quarter)	0.80M	0.60M	0.13M	3.09M	5.18M	0.13M	9.88M	2.80M	5.01M	0.04M	0.04M	0.04M	0.01M
Current Leases (Quarter)	1.04M	1.07M	1.10M	1.14M	1.17M	1.21M	1.24M	1.28M	1.32M	1.36M	1.40M	1.44M	1.48M	1.52M	1.56M	1.61M	1.65M	1.70M	1.74M	1.63M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	23.61M	18.74M	17.14M	17.01M	15.12M	15.63M	17.47M	12.64M	14.36M	16.39M	31.54M	31.89M	25.92M	23.98M	11.62M	11.82M	11.62M	13.33M	17.06M	20.69M
Non-Current Liabilities
Non-Current Debt (Quarter)	18.20M	18.37M	18.55M	15.64M	13.73M	11.61M	9.39M	15.98M	13.97M	11.32M		15.91M		10.74M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	6.82M	6.54M	6.25M	5.96M	5.65M	5.33M	5.01M	4.68M	4.33M	3.98M	3.61M	3.24M	2.86M	2.46M	2.05M	1.63M	1.21M	0.76M	0.31M
Other Non-Current Liabilities (Quarter)	0.80M	0.60M	0.13M	0.02M	0.02M	0.02M	0.02M	0.02M	2.52M	0.02M	0.04M	0.04M
Total Non-Current Liabilities (Quarter)	47.83M	43.05M	41.82M	38.60M	34.50M	32.57M	31.86M	33.30M	32.66M	34.18M	35.93M	35.13M	28.78M	26.44M	13.67M	13.45M
Total Liabilities (Quarter)	48.63M	43.65M	41.95M	38.62M	34.52M	32.60M	31.88M	33.32M	35.19M	34.20M	35.97M	35.18M	28.78M	26.44M	13.67M	13.45M	12.82M	14.09M	17.37M	20.69M
Shareholder's Equity
Total Debt (Quarter)	19.00M	18.97M	18.68M	18.73M	18.91M	11.75M	19.27M	18.78M	18.98M	11.36M	0.04M	15.95M	0.01M	10.74M
Common Equity (Quarter)	91.52M	76.96M	77.63M	69.11M	61.16M	49.47M	41.95M	32.99M	16.46M	9.52M	0.31M	-6.91M	96.97M	125.54M	150.50M	142.43M	127.11M	110.99M	92.15M	147.50M
Shareholder's Equity (Quarter)	91.52M	76.96M	77.63M	69.11M	61.16M	49.47M	41.95M	32.99M	16.46M	9.52M	0.31M	-6.91M	96.97M	125.54M	150.50M	142.43M	127.11M	110.99M	92.15M	147.50M
Liabilities and Shareholders Equity (Quarter)	140.15M	120.61M	119.57M	107.73M	95.68M	82.07M	73.83M	66.31M	51.65M	43.72M	36.28M	28.27M	125.74M	151.98M	164.17M	155.88M	139.93M	125.08M	109.51M	168.19M
Retained Earnings (Quarter)	-0.03M	-337.30M	-339.47M	-349.73M	-359.17M	-0.12M	-0.21M	-392.08M	-0.07M	-418.61M	-0.01M	-436.68M	-443.58M	-0.39M	-467.40M	0.04M	-493.87M	-511.50M	-534.88M	-555.43M
Treasury Shares (Quarter)									0.02M	0.02M	0.02M	0.02M

Research Tools

Corbus Pharmaceuticals Holdings Balance Sheet (2013-2025) | CRBP

Create an account

Sign In

Reset Password